| human | Q5 |
| P496 | ORCID iD | 0000-0003-4889-6849 |
| P106 | occupation | researcher | Q1650915 |
| Q36402045 | A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. |
| Q43458651 | Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome |
| Q33815631 | Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. |
| Q33847973 | Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults. |
| Q35533586 | Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions. |
| Q47402442 | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease |
| Q34312702 | Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors |
| Q24539030 | Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission |
| Q90441813 | Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation |
| Q36212400 | Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation |
| Q36920466 | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease |
| Q37183578 | Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation |
| Q34541742 | Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group |
| Q35769347 | Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival |
| Q37685590 | Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. |
| Q93021290 | Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children |
| Q37076418 | Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease |
| Q64089252 | Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease |
| Q42139164 | IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo |
| Q35692767 | IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults |
| Q37097096 | Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. |
| Q58415027 | Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation |
| Q34577019 | Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. |
| Q36036340 | Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. |
| Q35525729 | Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. |
| Q42737854 | Prediction of veno-occlusive disease using biomarkers of endothelial injury |
| Q35848361 | Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease |
| Q46816156 | Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts |
| Q39143739 | Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation |
| Q36430103 | Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 |
| Q34827332 | Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation |
| Q33650918 | White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome |
Search more.